Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.

SZSE:301093 주식 보고서

시가총액: CN¥2.8b

Jiangsu Hualan New Pharmaceutical MaterialLtd 미래 성장

Future 기준 확인 5/6

Jiangsu Hualan New Pharmaceutical MaterialLtd is forecast to grow earnings and revenue by 43.1% and 28% per annum respectively. EPS is expected to grow by 41% per annum. Return on equity is forecast to be 7.5% in 3 years.

주요 정보

43.1%

수익 성장률

41.0%

EPS 성장률

Medical Equipment 수익 성장27.5%
매출 성장률28.0%
향후 자기자본 수익률7.5%
애널리스트 커버리지

Low

마지막 업데이트07 Sep 2024

최근 미래 성장 업데이트

Recent updates

Weak Statutory Earnings May Not Tell The Whole Story For Jiangsu Hualan New Pharmaceutical MaterialLtd (SZSE:301093)

Sep 03
Weak Statutory Earnings May Not Tell The Whole Story For Jiangsu Hualan New Pharmaceutical MaterialLtd (SZSE:301093)

Is Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (SZSE:301093) Trading At A 36% Discount?

Jun 07
Is Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (SZSE:301093) Trading At A 36% Discount?

수익 및 매출 성장 예측

SZSE:301093 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (CNY Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/20261,158248N/A2431
12/31/2025898176N/A1911
12/31/2024722129N/A1671
9/30/20245928114215N/A
6/30/2024604953263N/A
3/31/202459395-6252N/A
12/31/2023623118-73224N/A
9/30/2023631106-124160N/A
6/30/202361998-118133N/A
3/31/202361096-129109N/A
1/1/202358494-7995N/A
9/30/202258610845178N/A
6/30/202269116490207N/A
3/31/2022784206114243N/A
1/1/202282121693217N/A
9/30/202178421466150N/A
6/30/202163315152116N/A
3/31/202150910361102N/A
12/31/20204468194133N/A
12/31/2019460955686N/A
12/31/20184348687107N/A
12/31/201738877N/A34N/A

애널리스트 미래 성장 예측

수입 대 저축률: 301093's forecast earnings growth (43.1% per year) is above the savings rate (2.9%).

수익 vs 시장: 301093's earnings (43.1% per year) are forecast to grow faster than the CN market (25.8% per year).

고성장 수익: 301093's earnings are expected to grow significantly over the next 3 years.

수익 대 시장: 301093's revenue (28% per year) is forecast to grow faster than the CN market (14% per year).

고성장 수익: 301093's revenue (28% per year) is forecast to grow faster than 20% per year.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: 301093's Return on Equity is forecast to be low in 3 years time (7.5%).

성장 기업 발견

7D

1Y

7D

1Y

7D

1Y